Hawa, Fadi
Vargas, Eric J.
Acosta, Andres
McRae, Alison
Bazerbachi, Fateh
Abu Dayyeh, Barham K.
Article History
Received: 11 March 2021
Accepted: 21 June 2021
First Online: 12 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: AA: Founder and stockholder: Gila Therapeutics, Phenomix Sciences. Consultant: Rhythm Pharmaceuticals, and General Mills. BKAD<b>:</b> Consultant: Metamodix, BFKW, DyaMx, Boston Scientific, USGI Medical, Hemostasis. Research support: Apollo Endosurgery, USGI, Spatz Medical, Boston Scientific, GI Dynamics, Cairn Diagnostics, Aspire Bariatrics, Medtronic. Speaker: Johnson and Johnson, Endogastric solutions, Olympus. The remaining authors declare that they have no competing interests.